StockData

Alumis vs Palatin Technologies

ALMS and PTN side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ALMS and PTN compare

Alumis is the larger company, worth 66 times as much as Palatin Technologies ($626M against $9.5M).

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricALMSPTN
Size and price
Market cap$626M$9.5M
Share price$4.84$5.36
Change, 1 year−12.3%−50.4%
Change, 5 years–−99.2%
Beta (5Y)2.170.11
Employees22425
StockData Score
Total score66
Valuation score11
Growth score01 (better)
Performance score00
Health score5 (better)4
Dividend score00
Valuation
P/S84.7×–
P/B1.4× (better)1.4×
FCF yield−56.2% (better)−142%
Profitability
Operating margin−6204%–
Net margin−5933%–
FCF margin−4755%–
Return on equity−93.6% (better)−878%
Financial health
Debt / equity0.000.00
Interest coverage–−1288.8×
Current ratio6.74 (better)4.61
Altman Z-score−1.13 (better)−76.12
Piotroski F-score24 (better)
Dividends and buybacks
Buyback yield–−177%
Shareholder yield0.00% (better)−177%
Ownership
Held by institutions91.3%38.5%
Held by insiders30.5%20.6%
Insider net buying, 12 months$44.7M (better)−$9.5K
Short interest, % of float12.3%20.9%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.